Amicus Therapeutics, Inc.
FOLD
$14.38
$0.010.07%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/17/2026
-
MarketBeat
3/17/2026
-
Ticker Report
3/16/2026
-
MarketBeat
3/16/2026
-
MarketBeat
3/16/2026
-
MarketBeat
3/15/2026
-
MarketBeat
3/15/2026
-
Simply Wall St
3/14/2026
-
MarketBeat
3/12/2026
-
Simply Wall St
3/11/2026
-
MarketBeat
3/5/2026
-
MarketBeat
3/5/2026
-
MarketBeat
3/4/2026
-
MarketBeat
3/4/2026
-
Simply Wall St
3/2/2026
-
MarketBeat
3/1/2026
-
MarketBeat
3/1/2026
-
MarketBeat
2/28/2026
-
MarketBeat
2/28/2026
-
Insider Monkey
2/26/2026
-
Ticker Report
2/26/2026
-
Tickeron - Stocks
2/26/2026
-
Simply Wall St
2/24/2026
-
Zacks Investment Research
2/24/2026
-
Simply Wall St
2/24/2026
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, February 20, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
609 662 2000
Address
47 Hulfish Street
Princeton, NJ 08542
Princeton, NJ 08542
Country
Year Founded
Business Description
Sector
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company’s...
more